Canadian Lung Association
Ottawa, ON K2C 2B5
President & CEO: Terry Dean
Board Chair: Anne Marie Downey
Charitable Reg. #: 10686 2998 RR0001
Grade: B+The grade is based on the charity's public reporting of the work it does and the results it achieves.
Need for Funding
Cents to the Cause
Full-time staff #9
Avg. Compensation $147,980
Top 10 Staff Salary Range
|$300k - $350k||0|
|$250k - $300k||0|
|$200k - $250k||0|
|$160k - $200k||1|
|$120k - $160k||1|
|$80k - $120k||0|
|$40k - $80k||6|
About Canadian Lung Association:
Founded in 1900, the Canadian Lung Association (CLA) is a charity consisting of a national office in Ottawa and 10 provincial Lung Associations that work together to improve lung health in Canada. The national office and each provincial association are separately registered charities – this profile is a report for the national office. CLA reports that lung disease is the third biggest killer in Canada, chronic lung disease accounts for more than 6% of annual healthcare costs in Canada, and Chronic Obstructive Pulmonary Disease (COPD) is the leading cause of hospitalization. To help these people, the charity funds research to find new treatments for lung disease, advocates for positive change in lung health, and educates Canadians on the causes and consequences of various lung diseases.
Research funding made up the majority of CLA’s program spending in F2017, accounting for 61% of program costs. The charity runs three research programs: the Kayla Baker Research Award, the National Respiratory Research Strategy and the Canadian Respiratory Research Network. In F2017, The Lung Associations collectively funded 45 research projects worth a total of nearly $1.7 million. The most number of projects focused on COPD and asthma.
CLA’s second biggest program was its communication and advocacy work, accounting for 34% of program costs in F2017. The association advocates primarily at the federal level for policy changes. In 2016, The Lung Association formed a partnership with The Heart and Stroke Foundation and The Canadian Cancer Society to address tobacco packaging, as smoking remains the number one cause of preventable lung disease.
Its third major program is the Consumer Health Information (CHI) program, which made up 5% of program costs in F2017. CLA runs a Lung Health Information line where people affected by lung disease speak with certified respiratory educators. The CHI program also includes local patient support groups run by the provincial Lung Associations and the Lung Health section of CLA’s website allows people to access more information on lung diseases, disease prevention and lung health.
In F2016, CLA transferred the operations of the Canadian Thoracic Society, Canadian Respiratory Conference and Canadian Respiratory Health Professionals divisions to the newly formed Canadian Thoracic Society Corporation, a registered not-for-profit. The transferring of these programs has resulted in a 57% decrease in CLA’s program costs in F2017 compared to F2016. The Association has transformed into a more research and advocacy focused charity rather than running its own programs.
After serving 2.5 years as Senior VP of Federation Development and Partnerships, Terry Dean was named the new President and CEO of Canadian Lung Association in June 2017.
Results and Impact: A researcher funded by Canadian Lung Association was the first to find that stem cells from bone marrow and umbilical cords can prevent and repair experimental neonatal lung injury. Phase 1 trials started taking place at the end of 2015. CLA’s advocacy work has led to the implementation of graphic health warnings on tobacco packages, taxation increases on tobacco products and improving access to cessation medication. This has helped reduce smoking rates in Canada from 26% in 2001 to 18% in 2017.1
Canadian Lung Association is a medium-sized charity with donations of $2.1m in F2017. Administrative costs are 34% of revenues and fundraising costs are 44% of donations. CLA’s administrative cost ratio rose significantly in F2017 due to its general administrative cost remaining relatively stable but total revenues decreased by 39% compared to F2016. Per dollar donated to the charity, $0.22 goes towards its programs and grants, falling well outside Ci’s reasonable range for overhead spending. CLA’s funding reserves of $1.8m can cover annual program costs and granting activities for 1.7 years.
Fundraising costs in F2017 increased by 14% from F2016 due to high amounts of consultant fees paid for its Breathing As One campaign. This is a national fundraising initiative started in 2015 to fund research and improve the quality of life for lung disease patients. CLA uses external fundraisers as part of its fundraising activities. In F2017, the charity reported paying $676k (75% of total fundraising costs) to external fundraisers. CLA has not reported the revenue raised by the external fundraisers on behalf of the charity for any of the past 4 years in its T3010 CRA filings.
See the notes in the "Comments added by the Charity" below regarding the charity's high full-time average compensation amount.
This charity report is an update that has been sent to Canadian Lung Association for review. Changes and edits may be forthcoming.
Updated on July 17, 2018 by Derek Houlberg.
Financial RatiosFiscal year ending March
|Administrative costs as % of revenues||34.1%||15.9%||13.8%|
|Fundraising costs as % of donations||43.5%||26.8%||26.6%|
|Program cost coverage (%)||166.9%||100.3%||110.1%|
Summary Financial StatementsAll figures in $s
|Fees for service||0||295,863||488,729|
|Program costs - International||0||74,992||19,098|
|Program costs - Canada||705,613||1,624,438||2,054,919|
|Cash flow from operations||(483,037)||40,943||(103,232)|